tykhr
sign in
free sign up
Biohaven Pharmaceutical Holding Co Ltd
Biotechnology
Healthcare
BHVN
94.37 M shares
NYSE US
traded
09 Apr 2025
listed
no
open
16.18
52 week high
53.74
high
19.30
52 week low
16.54
low
15.79
growth
-46.81 %
previous Close
16.54
P/E ratio
-11
market cap
3.66 B
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-160.30 M
49.87 %
eps
-1.74 %
50.29 %
eps surprise
-12.21 %
net profit margin
-16030400000.00 %
0.00 %
operating incoming
-178.17 M
46.62 %
net change in cash
-154.30 M
-381.58 %
cash on hand
84.39 M
-64.71 %
cost of revenue
0.00 %
top